The pro-drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non-steroidal anti-inflammatory drugs. [electronic resource]
Producer: 19920318Description: 593-8 p. digitalISSN:- 0269-2813
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Cyclooxygenase Inhibitors -- pharmacology
- Edetic Acid -- pharmacokinetics
- Humans
- Indomethacin -- adverse effects
- Intestinal Diseases -- chemically induced
- Intestinal Mucosa -- metabolism
- Intestines -- drug effects
- Mannitol -- pharmacokinetics
- Middle Aged
- Permeability -- drug effects
- Prodrugs -- adverse effects
- Sulindac -- adverse effects
- Urea -- blood
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.